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Abstract
Background: Parkinson’s disease is the second most common neurodegenerative disorders after Alzheimer’s
disease. The main cause of the disease is the massive degeneration of dopaminergic neurons in the substantia
nigra. Neuronal apoptosis and neuroinflammation are thought to be the key contributors to the neuronal
degeneration.
Results: Both CATH.a cells and ICR mice were treated with 1-methyl-4-phenylpyridin (MPP+) to induce neurotoxicity in
vitro and in vivo. Western blotting and immunohistochemistry were also used to analyse neurotoxicity, neuroinflammation
and aberrant neurogenesis in vivo. The experiment in CATH.a cells showed that the treatment of MPP+ impaired intake of
cell membrane and activated caspase system, suggesting that the neurotoxic mechanisms of MPP+ might include both
necrosis and apoptosis. Pretreatment of lithospermic acid might prevent these toxicities. Lithospermic acid possesses
specific inhibitory effect on caspase 3. In mitochondria, MPP+ caused mitochondrial depolarization and induced endoplasmic
reticulum stress via increasing expression of chaperone protein, GRP-78. All the effects mentioned above were reduced by
lithospermic acid. In animal model, the immunohistochemistry of mice brain sections revealed that MPP+ decreased the
amount of dopaminergic neurons, enhanced microglia activation, promoted astrogliosis in both substantia nigra and
hippocampus, and MPP+ provoked the aberrant neurogenesis in hippocampus. Lithospermic acid significantly attenuates
all of these effects induced by MPP+.
Conclusions: Lithospermic acid is a potential candidate drug for the novel therapeutic intervention on Parkinson’s disease.
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Background
Parkinson’s disease (PD) is characterized by the selective
loss of dopaminergic neurons and neuroinflammation in
the substantia nigra (SN) [1–3]. Even after numerous
studies, the cause of dopaminergic cell degeneration in
SN of PD patients still has not been identified with
certainty. Therefore, several experimental models for the
therapeutic research on PD have been developed to
investigate the pathogenesis and pathophysiology
of PD [4, 5].
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), a
neurotoxin that can induce symptoms similar to those
observed in PD patients [6] and induces selective loss of
dopaminergic neurons in SN of mice [4, 5]. MPTP must be
converted into 1-methyl-4- phenylpyridine (MPP+) in the
glial cells and then taken up by dopaminergic neurons via
the dopamine transporter. Consequently, MPP+ is concen-
trated inside the mitochondria where it potently inhibits
complex I of the electron transport system [7]. This result
in ATP depletion, loss of mitochondrial membrane poten-
tial, and the formation of reactive oxygen species (ROS)
and reactive nitrogen species (RNS), activation of caspase-9
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and −3 [8], increasing intracellular Ca2+ concentrations [9],
enhancing endoplasmic reticulum (ER) stress [10, 11], and
results in programmed cell death.
Several lines of evidence suggest that apoptotic cell death
of dopaminergic neurons in PD is driven in part by neuro-
inflammation [12, 13]. The production of toxic levels of
ROS and RNS by activated microglia is believed to be a
major threat for dopaminergic neurons survival [12]. Per-
sistent microglial activation has been detected in the SN of
humans and mice [14, 15]. Moreover, the short-term MPTP
induced a significant increase in the numbers of newborn
type1 and type2a neurons which represent a subpopulation
of rarely dividing cells with glial characteristics, which are
suggested to give rise to immature neurons in the course of
adult neurogenesis [16].
A variety of polyphenolic compounds has been isolated
from Tournefortia sarmentosa Lam. (Boraginaceae)
(Chinese name: Teng Zi Dan), widely used in Taiwan as
a detoxicant and anti-inflammatory agent [17]. Most of
these polyphenolic compounds possess antioxidative
activity, including tournefolic acid B (TAB), TAB methyl
ester (TABM), and lithospermic acid (LSA). The TAB
and TABM exhibit neuroprotective potency against
glutamate-, NMDA-, and Aβ-mediated neurotoxicity
[18–20]. LSA was also extracted from Salvia miltiorrhiza
Bge (Labiatae) [21] and Origanum vulgare [22], and has
been investigated to possesses the effects on anti-oxidation
and anti-inflammation [23]; and anti-atherosclerosis [24].
In this study, we use both cell and animal models for PD.
To study the MPP+-mediated neurotoxicity in vitro, murine
dopaminergic neuron cell line (CATH.a) was employed ac-
cording on their activity to synthesize abundant dopamine
and norepinephrine and expressing the appropriate cate-
cholaminergic biosynthetic enzymes, tyrosine hydroxylase
(TH) and dopamine β-hydroxylase [25]. For comparison,
primary cortical neurons, in which doparminergic neuron
is not the major neuronal type, were also employed. On the
other hand, to examine the MPP+-mediated neurotoxicity,
neuroinflammation, and neurogenesis in vivo, intracerebral
ventricle (icv)-injection of MPP+ in mice was used. The ob-
jective of this study was to investigate influence of LSA on
MPP+-induced neurotoxicity alone and neurotoxicity with
neuroinflammation and neurogenesis in cell and animal
models, respectively. Our results demonstrated that LSA
effectively reduced MPP+-induced neurotoxicity in vitro
and in vivo. Furthermore, LSA effectively attenuated neu-
roinflammationm and the aberrant neurogenesis in vivo.
Methods
Cell cultures and treatments
CATH.a cells were cultured in RPMI 1640 medium con-
taining 10 units/ml penicillin, 10 μg/ml streptomycin, 4 %
fatal bovine serum and 6 % horse serum.
Primary cultures of neonatal cortical neurons were
prepared from the cerebral cortex of Sprague Dawley rat
pups at postnatal day 1 as described previously [26].
Briefly, pups were anesthetized with ether and sacrificed
by decapitation. The cortex was digested in 0.5 mg/ml
papain at 37 °C for 15 min and dissociated in Hibernate
A medium (containing B27 supplement) by trituration.
Cells were plated (5 × 104 cells/cm2) onto poly-L-lysine-
coated plates and maintained in Neurobasal medium
containing B27 supplement, 10 units/ml penicillin,
10 μg/ml streptomycin, and 0.5 μg/ml glutamine (5 %
CO2/9 % O2) for 3 days. Cells were then exposed to
cytosine-β-D arabinofuranoside (5 μM) for 1 day to
eliminate the proliferation of non-neuronal cells. The
cells were used for the experiment on the fifth day.
CATH.a cells or cortical neurons were pre-treated
with vehicle, LSA or TAB for 30 min and then MPP+
were added into the culture for inducing neurotoxicity.
Measurement of cell viability
The calcein/ethidium homodimer-1 staining and the re-
duction of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetra-
zolium bromide (MTT) were used to evaluate cell
viability. Cells were loaded with 1 μM of both calcein AM
and ethidium homodimer-1 at room temperature for
30 min. The cells were observed by laser-scanning con-
focal fluorescence microscope (Leica CS SP, Wetzlar,
Germany; Zeiss LSM780, Carl Zeiss, Jena, Germany). Cells
were incubated with 0.5 mg/ml MTT for 1 h. The forma-
zan particles were dissolved with dimethyl sulfoxide
(DMSO). OD600 nm was measured using an ELISA
reader.
Measurement of superoxide anion (O2
−.)
The intracellular level of O2
−. was measured by dihy-
droethidium assay as described previously [19]. Treated
cells were loaded with 3.2 μM dihydroethidium at 37 °C
for 30 min and then observed by a Leica DMIRB fluor-
escence microscope. The intensity of fluorescence in nu-
clear position was measured by using MetaMorph
software (Universal Imaging Co., West Chester, PA).
Determination of mitochondrial membrane potential
Cells were treated with MPP+ (300 μM) or MPP+ combined
with LSA (100 μM) for 2 hours, and then cells were loaded
with 100 nM Tetramethyl Rhodamine Methyl Ester
(TMRM) at 37 °C for 20 min. After wash with Hanks’ bal-
anced salt solution (HBSS; 137 mM NaCl, 5.4 mM KCl,
0.4 mM KH2PO4, 4.2 mM NaHCO3, 0.5 mM MgCl2,
0.6 mMMgSO4, and 5.6 mM D-glucose, pH 7.4), cells were
incubated in HBSS containing 2 mM CaCl2. The fluores-
cence of TMRM was detected by a Leica DMIRB fluores-
cence microscope with an excitation wavelength of 555 nm.
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Immunoblots
For Western blot analysis, samples (6 μg protein) were
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (15 % gels) and were then transferred to
PVDF membranes. The primary antibodies used were as
follows: mouse monoclonal antibody to actin and α-
spectrin (Invitrogen), rabbit polyclonal antibody to cas-
pase 3 (Millipore), cleaved caspase 3, caspase 7, cleaved
caspase 7, caspase 9, cleaved caspase 9, caspase 12,
cleaved poly ADP ribose polymerase (PARP), c-jun N-
terminal kinase (JNK), pJNK(T183/Y185) (Cell signal-
ling) and 78 kDa glucose-regulated protein (GRP-78)
(Santa Cruz). The secondary antibodies were anti-rabbit
IgG antibody conjugated with horseradish peroxidase (GE
Healthcare) and anti-mouse IgG antibody conjugated with
horseradish peroxidase (Jackson ImmunoResearch). En-
hanced chemiluminescence detection reagents (GE Health-
care) were used for detection. Bands were quantified using
Fujifilm LAS-3000 Luminescent Image Analyzer (Tokyo,
Japan).
Animals and treatment
The Institutional Animal Care and Use Committee at
the National Research Institution of Chinese Medicine
approved the animal protocol (IACUC No: 95-A-08). Six
week-old male ICR mice were housed for 1 week under
standard conditions at 25 ± 2 °C with a 12-h light/dark
cycle and were allowed free access to water and standard
chow. Administration (icv) of MPP+ (12 μg in 2 μl sa-
line) was performed unilaterally on male ICR mice
(8 weeks old). The mice were anesthetized with intraper-
itoneal (ip) chloral hydrate (Sigma; 0.4 g/kg body weight,
maintained with 0.1 g/kg hourly) and fixed into a stereo-
taxic apparatus. The dorsal surface of the skull was ex-
posed with a midline incision, and a burr hole was
drilled at the following coordinates: anteroposterior,
0.22 mm caudal to bregma and 1 mm right lateral to
midline. A 10-μl Hamilton syringe fitted with a 25-gauge
needle was pre-loaded by 1 μl MPP+ solution (12 μg
MPP+ in 1 μl saline) followed by 1 μl LSA solution (5 μg
LSA in 1 μl saline). The injection syringe was placed
over the burr hole and lowered 2.5 mm into the surface
of the brain, and the solution was injected at a rate of
0.2 μl/min. The needle was then left in place for 2 min
before it was slowly retracted. Control animals were
injected with saline. MPP+ is injected into lateral ven-
tricle to induce a Parkinson-like syndrome and lost of
dopaminergic neurons in SNPc, and the proper dose is
determined by trial test. The final amount of MPP
injected was set at 12 μg MPP+.
Tissue processing
At day 5 post MPP+ injection and vehicle injection, mice
were deeply anesthetized with chloral hydrate and
perfused through the heart with 30 ml of saline followed
by 30 ml of fixative solution containing 4 % formalde-
hyde in saline. The brain was removed, post-fixed in 4 %
formaldehyde for 18 h at 4 °C and cryoprotected in 30 %
sucrose solution in 0.1 M phosphate-buffered saline
(PBS). A cryostat was used to cut 30-μm coronal sec-
tions through the dorsal hippocampus, which were col-
lected serially in PBS.
Immunohistochemistry
Brain sections were incubated in blocking solution (PBS
containing 5 % normal goat serum, 2 % Triton X-100,
0.02 % bovine serum albumin) overnight at 4 °C and left
overnight at 4 °C in staining solution (PBS containing 5 %
normal goat serum, 0.25 % Triton X-100, 0.02 % bovine
serum albumin) with primary antibodies, including mouse
monoclonal antibody to glial fibrillary acid protein (GFAP)
and tyrosin hydrolase (TH) (Invitrogen); rabbit polyclonal
antibody to doublecortin (Abcam); and mouse monoclonal
antibody to ionized calcium-binding adaptor molecule-1
(Iba-1, Abcam). Sections were then incubated in staining
solution containing Hoechst33258 (Invitrogen, 2 μg/ml),
Fluorescein isothiocyanate-conjugated goat anti-mouse IgG
and cy5-conjugated goat anti-rabbit IgG or cy5-conjugated
goat anti-rabbit IgG (1:200; Jackson ImmunoResearch) in
the dark overnight at 4 °C. Sections were then washed in
PBS and mounted with Aqua Poly/Mount (Polyscience
Inc., Warrington, PA, USA). The sliced tissues were exam-
ined using a laser-scanning confocal microscope (Zeiss
LSM780; Carl Zeiss, Jena, Germany).
Quantitative immunofluorescence analysis
All analyses were calculated within a field (250 ×
250 μm2) of substantia nigra pars reticulata (SNpr), sub-
stantia nigra pars compacta (SNpc), Cornu Ammonis
(CA)1 and dentate gyrus (DG). The expression of GFAP
and Iba-1 expression was calculated from the immuno-
reactivity (IR) of each protein that displayed as the op-
tical density (arbitrary unit) of each image.
Statistic analysis
The results are expressed as the mean ± standard devi-
ation (S.D.) and were analyzed by analysis of variance
(ANOVA) with post hoc multiple comparisons corrected
with Bonferroni tests.
Results
MPP+ mediates neurotoxicity in CATH.a cells and cortical
neurons through distinct mechanisms
Treatment with MPP+ elicited cell death of CATH.a cells
and cortical neurons in a concentration-dependent man-
ner as determined by MTT reduction (Fig. 1a). MPP+
(300 μM) elicited cell death of CATH.a cells and cortical
neurons by 51.65 ± 2.80 % and 52.66 ± 10.12 %, respectively.
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Morphologically, MPP+-provoked cell death of CATH.a
cells and cortical neurons coincided with the appearance of
cell atrophy and discontinuous neurites, respectively
(Fig. 1b). Proteolytically, treatment with MPP+ induced
cleavage of α-spectrin in cortical neurons but not in
CATH.a cells. In cortical neurons, both the 150- and 145-
kDa protein fragments (the activity of calpain), but not the
120-kDa fragment (the activity of caspase 3), were signifi-
cantly appeared after the treatment of MPP+ (Fig. 1c, d).
LSA protect CATH.a cells but not cortical neurons against
MPP+-mediated neurotoxicity
The effects of TABM and LSA on MPP+-induced neuro-
toxicity were investigated. From Fig. 1a, the concentration
of MPP+ to induce 50 % cell death is 250 μM. Therefore, in
this assay 250 mM MPP+ were adopted. The structure of
TABM and LSA were showed in Fig. 2a. TABM and LSA
at 100 μM did not significantly alter the cell viability of
both cells (Data not shown). To cortical neurons, both
TABM and LSA fail to ameliorate the detrimental effect of
MPP+ (Fig. 2b, c). To CATH.a cells, the MPP+-mediated
cell death was 33.06 % attenuated by 100 μM TABM
(Fig. 2b), and was significantly attenuated by LSA in a
concentration-dependent manner. LSA at 50 and 100 μM
abrogated MPP+-mediated CATH.a cell death by 42.29 %
and 83.19 %, respectively (Fig. 2c).
For determining the MPP+-mediated death pathways of
CATH.a cells, calcein/ethidium homodimer-1 staining was
employed. Treatment with MPP+ elicited both apoptosis
and necrosis of CATH.a cells in a concentration-dependent
manner (Fig. 3). MPP+ (400 μM) did not significantly affect
calcein fluorescence (apoptosis), and elicited increase of
Fig. 1 The Neurotoxicity of MPP+ on CATH.a cells and primary cortical neurons. a, b CATH.a cells and cortical neurons were cultured with various
concentrations of MPP+ for 24 hours. The cell viability of CATH.a cells (opened bars) and cortical neurons (closed bars) were detected by MTT
reduction assay (a). Results are means ± S.D. from three independent experiments. Significant differences between the cells treated with vehicle
and MPP+ were indicated by ***, P < 0.001. The representative phase contrast morphology of the treated cells is shown in panel
(b). Scale bar: 50 μm. The representative immunoblots of α-spectrin, spectrin degraded fragments and β-actin are shown in panel (c). In cortical
neurons, the activation of calpain cleaved 250-kDa α-spectrin (opened bars) to produce 150- (closed bars) and 145-kDa (dark gray bars) fragments,
whereas activation of caspase 3 generated 120- (light gray bars) and 150-kDa fragments of α-spectrin (d). Results are means ± S.D. from three
independent experiments. Significant differences between the cells treated with vehicle and MPP+ were indicated by ***, P < 0.001
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ethidium homodimer-1 fluorescence (necrosis) by 9.35
folds of control. On the other hand, 600 μM MPP+ elicited
reduction of calcein fluorescence and increase of ethidium
homodimer-1 fluorescence by 39.25 % and 11.58 folds of
control, respectively, and 50 μM LSA attenuated those
values to 11.40 % and 6.17 folds of control (Fig. 3).
LSA blocked the MPP+-induced accumulation of
superoxide anion and decrease of mitochondrial
membrane potential
Dihydroethidium was used to measure the intracellular
level of superoxide anion (O2
−.). Treatment with MPP+ sig-
nificantly provoked O2
−. accumulation initially at 30 min
and peaked at 120 min (Fig. 4). Treatment with MPP+
(300 μM ) for 30, 90, and 120 min elevated the level of O2
−.
to 167.3 ± 50.9, 234.9 ± 53.9, and 242.9 ± 20.9 % of control,
respectively. LSA (100 μM) diminished the MPP+-induced
O2
−. accumulation by 55.37 % (Fig. 4b).
TMRM was used to verify whether LSA modulated
the mitochondrial membrane potential. Treatment with
MPP+ significantly diminished mitochondrial membrane
potential as soon as at 30 min (Fig. 4). Treatment with
300 μM MPP+ for 30, 90, and 120 min decreased the
level of membrane potential to 30.93 ± 1.23, 26.45 ± 1.29,
and 21.03 ± 4.07 % of control, respectively. LSA (100 μM)
significantly recovered the MPP+-induced decrease of
membrane potential by 17.23 % (Fig. 4).
LSA Blocked the MPP+-Induced Pro-apoptotic responses
MPP+ time-dependently induced ER stress in CATH.a cells
and increased expression of ER chaperones (GRP-78). MPP
+ also triggered apoptosis by decreasing the level of the cas-
pase 7 and 9, and increasing the level of cleaved caspase 3
and PARP. Treatment with MPP+ (300 μM ) for 24 hour
significantly provoked GRP-78, caspase 7, caspase 9,
cleaved caspase 3 and cleaved PARP to 252.48 ± 55.90,
48.60 ± 11.87, 49.73 ± 7.34, 170.39 ± 9.12 and 215.28 ± 41.17
of the control, respectively (Fig. 5a). LSA treatment signifi-
cant prevented the level increase of GRP-78, cleaved cas-
pase 3 and cleaved PARP. Treatment with MPP+ (300 μM )
for 8 hour significantly provoked GRP-78, caspase 7, cas-
pase 9, cleaved caspase 3 and cleaved PARP to 162.63 ±
32.50, 73.71 ± 6.32, 63.14 ± 19.45, 166.39 ± 8.88 and 156.78
± 25.04 of the control, respectively (Fig. 5b). LSA (100 μM)
diminished the MPP+-induced level increase of GRP-78,
cleaved caspase 3 and cleaved PARP to 86.38 ± 34.49,
124.76 ± 6.41 and 89.18 ± 16.99 of the control, respectively
(Fig. 5b). Alternatively, LSA did not significantly affected
MPP+-induced level decrease of caspase 7 and caspase 9.
These results indicate that LSA may protect Cath.a cells
against MPP+ activated ER stress and the associated apop-
tosis specifically target on caspase 3, but not on caspase 7
and 9.
Icv-MPP+-injection-induced lost of dopaminergic neurons
in SNpc were attenuated by icv-LSA-injection
To explore the in vivo neurotoxicity of MPP+ and neuro-
protective activity of LSA, the intracerebral ventricular in-
jection of MPP+ (icv-MPP+-injection, 12 μg in 2 μl saline)
alone or MPP+ combined with LSA (icv-MPP+-LSA-injec-
tion, 12 μg and 5 μg, respectively, in saline) were performed
at single-side lateral ventricle of ICR mice. The mice were
sacrificed 5 days later and the survival of the dopaminergic
neurons were detected by immunostaining of TH. The re-
sults showed that icv-MPP+-injection reduced the TH-
immunoreactivity in ipsilateral and contralateral side of
SNpc to 51.2 ± 5.1 % and 70.86 ± 6.0 % of the control, re-
spectively (Fig. 6). Co-treatment of LSA with MPP+
Fig. 2 The effect of TABM and LSA on the Neurotoxicity of MPP+. CATH.a cells (opened bars) and cortical neurons (closed bars) were pretreated
with various concentrations of TABM (a) or LSA (b) for 30 min, and then the cells were cultured with 250 μM MPP+ for 24 hours. Cell viability was
mesured using MTT reduction assay. Results are means ± S.D. from three independent experiments. Significant differences between the cells
treated with MPP+ combined with TABM or LSA were indicated by *, P < 0.05; ***, P < 0.001
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recovered the lost TH-immunoreactivity in ipsilateral
side of SNpc to 64.7 ± 6.9 % and 83.89 ± 16.3 % of the
control, respectively.
Icv-MPP+-injection-induced activation of microglia in SNpr
and CA1 were attenuated by icv-LSA-injection
To examine the pro-inflammatory effects of MPP+, astro-
cytes and microglia were detected by immunostained with
anti-GFAP and anti-Iba-1 antibodies, respectively. The re-
sults showed that icv-MPP+-injection increased the GFAP-
postive astrocytes in CA1 area (to 138.9 % of the control)
but not in SNpc and SNpr. The increased GFAP-positive as-
trocytes in CA1 area was attenuated by the co-treatment of
LSA with MPP+ (to 101.5 % of the control). On the other
hand, icv-MPP+-injection increased the Iba-1-postive micro-
glia in both SNpr and CA1 area to 176 % and 9 folds of the
control, respectively (Fig. 7). Co-treatment of LSA with
MPP+ reduced the Iba-1-postive microglia in SNpr and
CA1 area to 118 % and 4.3 folds of the control, respectively.
Icv-MPP+-injection-induced activation of radial glial-like
stem cells and new-borne neurons in subgranular zone
were attenuated by icv-LSA-injection
To examine the promoting effects of MPP+ on neurogen-
esis, the radial glial-like stem cells and the new-borne
neurons were detected by immunostained with anti-GFAP
and anti-doublecortin antibodies, respectively. The results
showed that icv-MPP+-injection increased the GFAP-
Fig. 3 The Neurotoxicity of MPP+ and neuroprotective effect of LSA in CATH.a cells detected by LIVE/DEAD cell viability assay. CATH.a cells were
either untreated (control) or pretreated with vehicle (MPP/veh), 50 μM LSA (MPP/50) or 100 μM LSA (MPP/100) for 30 min before the stimulation
of 600 μM MPP+ for 24 hours. The LIVE/DEAD cell viability assay was employed to detect the cell viability. The representative images of the phase
contrast (Phase), calcein (green) and EthD-1 (red) are shown in panel (a). Panel (b) and (c) are the fluorescence (arbitrary unit, AU) of calcein and
EthD-1, respectively. Results are means ± S.D. from three independent experiments. Significant differences between the cells treated with vehicle
and MPP+ were indicated by ***, P < 0.001. Significant differences between the cells treated with MPP+ combined with vehicle (veh) and LSA
were indicated by ###, P < 0.001
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positive astrocytes/radial glial-like stem cells and
doublecortin-positive new borne neurons in DG area to 291
% and 142 % of the control, respectively (Fig. 8). Co-
treatment of LSA with MPP+ reduced these value to 128.7
% and 73.3 % folds of the control, respectively.
Discussion
In the present study, the in vitro model (CATH.a cells, a
dopaminergic neuron cell line) demonstrated that LSA ab-
rogated MPP+-mediated neurotoxicity as determined by
MTT reduction, calcein/ethidium homodimer-1 staining,
and morphological observation. LSA attenuated the MPP
+-mediated effects, including accumulation of O2
−., decrease
of mitochondrial membrane potential, activation of the cas-
pase cascade, and thereby protected CATH.a cells against
MPP+-mediated neurotoxicity. Both necrosis and apoptosis
are implicated in this neurotoxicity. Moreover, the in vivo
model (icv-MPP+-injection of ICR mice) demonstrated that
LSA effectively attenuate MPP+-mediated loss of dopamin-
ergic neurons in SNpc, astrogliosis in hippocampus,
Fig. 4 The MPP+-induced production of superoxide anion and decrease of mitochondrial membrane potential in CATH.a cells were
attenuated by LSA. CATH.a cells were either cultured with 300 μM MPP+ for various time-periods or pretreated with 100 μM LSA for
30 min, and then were cultured with 300 μM MPP+ for 120 min. After treatments, superoxide anion and mitochondrial membrane potential
were detected by the fluorescence of hydroethidine (HEt) and TMRM, respectively. The representative images are shown in panel (a). Panel (b) is
the relative fluorescence (% of control) of TMRM (opened bars) and HEt (closed bars). Results are means ± S.D. from three independent experiments.
Significant differences between the cells treated with vehicle and MPP+ were indicated by *, P < 0.05, ***, P < 0.001. Significant differences between the
cells treated with 300 μM MPP+ alone (C) and 300 μM MPP+ combined with LSA were indicated by #, P < 0.05; ##, P < 0.01
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microglial activation in both SNpr and CA1 areas, and ab-
errant neurogenesis in hippocampus.
In the in vitro assay, LSA and TAB were added into
cell culture 30 min before the stimulation of MPP+ to
prevent those pre-mixed with MPP+. In the in vivo assay,
LSA solution was injected with MPP+ solution in the
same syringe but without pre-mixed.
Previously, MPP+ has been suggested to induce neuro-
toxicity in dopaminergic neurons [7]. For verifying the
above statement, dose response of MPP+-mediated
neurotoxicity was performed on two different cell types
(i.e. CATH.a cells and cortical neurons). CATH.a cells, a
mouse brain-derived catecholaminergic neuron cell, syn-
thesizes abundant dopamine and norepinephrine and ex-
presses the appropriate TH and dopamine β-hydroxylase
[25]. Previously, CATH.a cells administrated with 200–
1000 μM MPP+ has been employed to be a cell model
for the mechanism studies on Parkinson’s diseases [27].
Besides the dopaminergic neurons, the primary cortical
neurons have also been reported to be accessible to
MPP+-mediated neurotoxicity [28, 29]. In our present
study, we use both CATH.a cell line and primary cortical
neurons to study the neurotoxic specificity mediated by
MPP+. Our results indicated that MPP+ mediates distinct
death pathway in CATH.a cells and the primary cortical
neurons although the dose response between these two cell
types was similar. The calpain-dependent cleavage of α-
spectrin is involved in the death of primary cortical neu-
rons, but not of CATH.a cells. The reason may be due to
that CATH.a cells is not a neurite-bearing mature neurons
[19, 30] and which may explain why LSA fail to protect the
primary cortical neurons against MPP+-mediated neuron
death. The previous reports suggested that calpain plays a
central role in MPP+ mediates cell death in spinal cord mo-
toneurons [31] and cerebellar granule neurons [32] may
supported this speculation.
Mitochondrion is involved in the activation of caspase 9
mediating by cytochrome c release. Therefore, the mito-
chondrion is a pivotal organelle implicating in apoptosis
[33]. Recently, ER has attracted attention as an intracellular
compartment in which disturbance of calcium homeostasis
may contribute to pathological processes culminating in
neuronal injury [34]. Mitochondrial superoxide anion
production and membrane potential loss has been reported
to be the primitive mechanism of MPP+-mediated neuron
death [35, 36]. In CATH.a cells, we also find that
Fig. 5 The MPP+-induced pro-apoptotic responses in CATH.a cells were attenuated by LSA. CATH.a cells were cultured with 300 μM MPP+
for various time-periods (a) or pretreated with 100 μM LSA for 30 min, and then were cultured with 300 μM MPP+ for 8 h (b). After
treatments, the indicated proteins were detected by western blotting and the representative images are shown. Lower part of panel (a) and
(b) are the relative protein level of GRP-78, caspase 7 (Casp7), caspase 9 (Casp9), cleaved caspase 3 (c-Casp3) and cleaved PARP (c-PARP).
The protein level has been normalized with GAPDH. Results are means ± S.D. from three independent experiments. Significant differences
between the cells treated with vehicle and MPP+ were indicated by *, P < 0.001. Significant differences between the cells treated with
300 μM MPP+ alone and 300 μM MPP+ combined with LSA were indicated by #, P < 0.001
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MPP+-induced superoxide anion production and mito-
chondrial membrane potential loss. These mitochondrial
effects were attenuated by LSA treatment suggested that
LSA may prevent the primitive mechanism of MPP+-medi-
ated neuron death on mitochondria.
MPP+-induced toxicity seems to involve activation of
unfolding protein response (UPR) and ubiquitin–prote-
asome system (UPS) dysfunction. In cell lines and pri-
mary dopaminergic neurons, MPP+ activates UPR;
however, which branches are upregulated varies by cell
Fig. 6 The icv-MPP+-injection-induced lost of dopaminergic neurons in SNpc were marginally attenuated by icv-LSA-injection. Two μl vehicle,
MPP+ (12 μg) alone or MPP+ (12 μg) combined with LSA (5 μg) were injected into lateral ventricle of ICR mice. The mice were sacrificed 5 days later. Brain
of the mice was subjected to cryosection and immunostained by anti-tyrosine hydrolase antibody (green). Panel (a) is the representative fluorescence
images. Panel (b) is the quantification of tyrosine hydrolase immunoreactivity. Results are means ± S.D. from three independent experiments. Significant
differences between the mice treated with vehicle and MPP+ were indicated by **, P < 0.01; ***, P < 0.001. Significant differences between the cells treated
with 300 μM MPP+ alone and 300 μM MPP+ combined with LSA were indicated by ##, P < 0.01.
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type [10, 11]. Many studies have demonstrated the in-
duction of at least some markers of apoptosis by MPP+
[37]. Exactly how MPP+ leads to cell death in dopamin-
ergic neurons is still unclear [37]. Many studies have
suggested that prolonged and severe UPR can lead to
cell death, possibly via apoptosis [38]. Amongst other
mechanisms, ER stress pathways have been hypothe-
sized to link to apoptosis [35]. Growing evidence sup-
ports that ER could operate in tandem with
mitochondria to regulate intracellular Ca2+ fluxes in
MPP+-induced cell death.
The caspase cascade responsible for executing cell death
following cytochrome c release is well described; however
the distinct roles of caspases-9, −3 and −7 during this
process are not completely defined. Caspase-9 can remodel
mitochondria and increase ROS production by cleaving Bid
into tBid. Also, caspase-3 can inhibit ROS production and
is the effector caspase necessary for efficient cell killing. In
contrast, caspase-7 has no significant role in sensitivity to
intrinsic cell death, but it is responsible for ROS production
and cell detachment [39]. Our data showed that mitochon-
dria dependent apoptosis triggered by MPP+, assessed by
the measurement of caspase 7 and 9 activation, is not
prevented by LSA treatment. However, LSA blocks the
MPP+-mediated increase in GRP-78 expression and caspase
3 activation suggesting that the ER stress but not the
Fig. 7 The icv-MPP+-injection-induced activation of glial cells in SNpr and CA1 were attenuated by icv-LSA-injection. 2 μl vehicle, MPP+
(12 μg) alone or MPP+ (12 μg) combined with LSA (5 μg) were injected into lateral ventricle of ICR mice. The mice were sacrificed 5 days
later. Brain of the mice was subjected to cryosection and immunostained by anti-GFAP antibody (green) and anti-Iba-1 antibody (red).
Panel (a) and (b) are the representative fluorescence images in SNpr/SNpc/PoDG and CA1 area, respectively. The right part of the panels is the
amplified images of the dotted square in the left part of the panel. Panel (c) and (d) is the quantification of GFAP and Iba-1 immunoreactivity of panel
(a) and (b), respectively. Results are means ± S.D. from three independent experiments. Significant differences between the mice treated with vehicle and
MPP+ were indicated by *, P < 0.05; **, P < 0.01; ***, P < 0.001. Significant differences between the mice treated with MPP+ alone and MPP+ combined with
LSA were indicated by ##, P < 0.01; ###, P < 0.001
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mitochondrial pathway may be regulated by LSA. In the
previous studies, the protein levels of GRP-78 in the
MN9D cells were up-regulated by 6-OHDA or MPP+ [11],
suggesting that ER stress is indeed a major pathway of
MPP+-mediated neuronal apoptosis or a survival effect to
save cells. Inhibition of complex I in mitochondria by MPP
+ triggers generation of ROS and RNS. As a result of close
proximity of mitochondria and ER, critical thiols of IP3R
are modified by mitochondrial ROS and RNS. Conse-
quently, IP3R channels are activated thereby enhancing ER
Ca2+ release, calpain activation and Bax cleavage. Cleavage
of Bax facilitates Bax oligomerization and formation of
death pores in the outer mitochondrial membrane that
leaks cytochrome c into the cytosol which, in turn, leads to
Fig. 8 The icv-MPP+-injection-induced activation of radial glial-like stem cells and new-borne neurons in subgranular zone were attenuated by
icv-LSA-injection. Two μl vehicle, MPP+ (12 μg) alone or MPP+ (12 μg) combined with LSA (5 μg) were injected into lateral ventricle of ICR mice.
The mice were sacrificed 5 days later. Brain of the mice was subjected to cryosection and immunostained by anti-GFAP antibody (green) and
anti-doublecortine antibody (DCX, red). Upper panel is the representative fluorescence images. Lower panel is the quantification of GFAP-labeled
radial glial-like cells and DCX-positive cells . Results are means ± S.D. from three independent experiments. Significant differences between the
mice treated with vehicle and MPP+ were indicated by ***, P < 0.001. Significant differences between the mice treated with MPP+ alone and
MPP+ combined with LSA were indicated by ###, P < 0.001
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apoptosome formation followed by caspase-9/caspase-3 ac-
tivation and apoptosis.
The ip-injection of MPTP is the most relevant animal
model of PD. On the other hand, to bypass the blood–
brain barrier, MPTP is injected stereotactically into the
brain. However, icv-injected MPTP induced no lesions
in the striatum or SNpc of C57BL/6 mice [40]. It is pos-
sible that icv-injected MPTP rapidly disappears from
CSF before the conversion to MPP+ and/or that MPTP
is detoxified by drug-metabolizing enzymes such as
glutathione S-transferase and cytochrome P450. There-
fore, icv-injection of MPP+ may be used to prohibit this
disadvantage. After icv injection, MPP+ initially affects
the dopaminergic cell body in the SNpc and then the
striatum to which dopaminergic cells project [40].
Previously, several polyphenols and polyphenol glycosides
have been demonstrated to be neuroprotective against
MPP+-mediated neurotoxicity that include puerarin [41];
tetrahydroxystilbene glucoside [42]; pedicularioside A [43];
myricetin [38]; pinocembrin [44]; daidzein [45]; acacetin
[46]; quercetin [47]. Moreover, salvianolic acid (Sal) B and
A, were also found to protect SH-SY5Y cells against MPP
+-induced apoptosis by relieving oxidative stress and
modulating the apoptotic process [48, 49]. The structure
of LSA is similar to Sal B and A. In acidic aqueous
solution, Sal B are found to be hydrolyzed into LSA,
and the latter was transformed into Sal A [50]. In
our present study, LSA was found to protect CATH.a
cells against MPP+-induced apoptosis by relieving oxi-
dative stress and modulating the apoptotic process.
Conclusion
In conclusion, LSA is potential for novel therapeutic
intervention for Parkinson’s disease.
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